Llwytho...
How to manage CML patients with comorbidities
Patients with chronic myeloid leukemia (CML) often have comorbidities, at an incidence that might be higher than in the general population. Because of the favorable outcome of most patients with CML treated with tyrosine kinase inhibitors (TKIs), a greater number of comorbidities might be the most s...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society of Hematology
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7727590/ https://ncbi.nlm.nih.gov/pubmed/33275749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2020006911 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|